Metabolic Dysfunction-associated Steatohepatitis
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis [Phase 3]
Phase 3 study evaluating denifanstat for metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH [Phase 3]
Phase 3 study evaluating denifanstat for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associat…